HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

Market Cap	131.40B
Revenue (ttm)	119.52B
Net Income (ttm)	5.70B
Shares Out	30.00M
EPS (ttm)	190.10
PE Ratio	10.67
Forward PE	7.73
Dividend	35.00 (0.80%)
Ex-Dividend Date	Dec 27, 2024

Volume	33,435
Average Volume	35,892
Open	4,340.00
Previous Close	4,355.00
Day's Range	4,330.00 - 4,395.00
52-Week Range	3,825.00 - 7,900.00
Beta	0.71
RSI	55.10
Earnings Date	May 14, 2025

About HYUNDAI BIOLAND

HYUNDAI BIOLAND Co.,Ltd. engages in the manufacture and sale of natural materials for cosmetics, nutraceuticals, and regenerative medicines worldwide. The company’s cosmetics includes whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products; and functional food ingredients comprising various nutraceuticals and general food raw ingredients. It is also involved in the provision of medical biomedical materials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supply of active ...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 320
• Stock Exchange: KOSDAQ
• Ticker Symbol: 052260

Financial Performance

In 2024, HYUNDAI BIOLAND's revenue was 119.52 billion, an increase of 23.57% compared to the previous year's 96.72 billion. Earnings were 5.70 billion, a decrease of -29.21%.